Pestell KE[au] - Search Results

Year	Number of Results
1998	1
2000	2
2002	2
2004	1
2023	0

1

Small molecule inhibitors of dual specificity protein phosphatases.

Pestell KE, Ducruet AP, Wipf P, Lazo JS. Pestell KE, et al. Oncogene. 2000 Dec 27;19(56):6607-12. doi: 10.1038/sj.onc.1204084. Oncogene. 2000. PMID: 11426646 Review.

2

Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.

Lazo JS, Nemoto K, Pestell KE, Cooley K, Southwick EC, Mitchell DA, Furey W, Gussio R, Zaharevitz DW, Joo B, Wipf P. Lazo JS, et al. Among authors: pestell ke. Mol Pharmacol. 2002 Apr;61(4):720-8. doi: 10.1124/mol.61.4.720. Mol Pharmacol. 2002. PMID: 11901209

3

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI. Pestell KE, et al. Mol Pharmacol. 2000 Mar;57(3):503-11. doi: 10.1124/mol.57.3.503. Mol Pharmacol. 2000. PMID: 10692490

4

Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivo.

Clarke PA, Pestell KE, Di Stefano F, Workman P, Walton MI. Clarke PA, et al. Among authors: pestell ke. Br J Cancer. 2004 Oct 18;91(8):1614-23. doi: 10.1038/sj.bjc.6602167. Br J Cancer. 2004. PMID: 15452549 Free PMC article.

5

Characterisation of the p53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines.

Pestell KE, Medlow CJ, Titley JC, Kelland LR, Walton MI. Pestell KE, et al. Int J Cancer. 1998 Sep 11;77(6):913-8. doi: 10.1002/(sici)1097-0215(19980911)77:6<913::aid-ijc19>3.0.co;2-1. Int J Cancer. 1998. PMID: 9714063 Free article.

6

The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activity.

Vogt A, Pestell KE, Day BW, Lazo JS, Wipf P. Vogt A, et al. Among authors: pestell ke. Mol Cancer Ther. 2002 Sep;1(11):885-92. Mol Cancer Ther. 2002. PMID: 12481409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year